跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOBUTAMINE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DOBUTAMINE INJECTION USP
Authorized
STANDARD
DOBUTAMINE INJECTION USP
hikma canada limited
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
94592fada4d6b8ff
Company
hikma canada limited
Type
Standard
Approval Details
Approval Id
94592fada4d6b8ff
Drug Approval Canada Name
DOBUTAMINE INJECTION USP
Product Name
DOBUTAMINE INJECTION USP
Status
Marketed
Status Date
2024-07-12
Original Market Date
2017-12-14
Din
02462729
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
12:12.08.08
Atc Original
C01CA07 DOBUTAMINE
Atc Name
c 01 ca 07
Aig Number
0112000001
Company Name
hikma canada limited
Company Address
5995 Avebury Road, Suite 804, Mississauga, Ontario, Canada, L5R 3P9
Active Ingredients
DOBUTAMINE (DOBUTAMINE HYDROCHLORIDE)
12.5 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
94592fada4d6b8ff
Type
Standard
Back to Health Canada Approvals